FDA Approves Extended Release Ruxolitinib for Three Rare Hematologic Disorders by Madaline Spencer| Published on: May 6, 2026

https://checkrare.com/fda-approves-extended-release-ruxolitinib-for-three-rare-hematologic-disorders/ The US Food and Drug Administration (FDA) has approved Jakafi XR (ruxolitinib) extended-release tablets for the treatment of three rare hematologic conditions.